1. Combined anti-MET/EGFR treatment results in complete tumor regression and prevents resistance onset in a MET-amplified gastroesophageal xenopatient cohort. (July 2016) Authors: Giordano, S.; Apicella, M.; Migliore, C.; Capeloa, T.; Menegon, S.; Cargnelutti, M.; Sapino, A.; Cassoni, P.; Marsoni, S.; Corso, S. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SP-0453 Targeting DNA repair to improve immunesurveillance and restrict cancer growth. (April 2019) Authors: Germano, G.; Lamba, S.; Rospo, G.; Barault, L.; Magrì, A.; Maione, F.; Russo, M.; De Braud, F.; Marsoni, S.; D'incalci, M.; Sartore-Bianchi, A.; Siena, S.; Pietrantonio, F.; Di Nicolantonio, F.; Bardelli, A. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗